Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss.
Frisone D, Charrier M, Clement S, Christinat Y, Thouvenin L, Homicsko K, Michielin O, Bodmer A, Chappuis PO, McKee TA, Tsantoulis P.
Frisone D, et al. Among authors: mckee ta.
Cancer Biol Ther. 2020;21(3):197-202. doi: 10.1080/15384047.2019.1685291. Epub 2019 Nov 10.
Cancer Biol Ther. 2020.
PMID: 31709901
Free PMC article.